New studies underway!

CODA Research is involved in two National Institute on Drug Abuse new studies. The links to these two trials are below:

“Accelerated Development of Additive Pharmacotherapy Treatment (ADAPT-2) for Methamphetamine Use Disorder. “

“Lorcaserin in the Treatment of Cocaine Use Disorder”

Interested in participating? Click on this blog’s home page and scroll down!

More News

The CATT’s Beaverton Site is Open!

Washington County News: On Monday, November 17th, the CATT’s Beaverton Recovery Center (BRC) site officially began admitting individuals into residential treatment and withdrawal management (detox) treatment. This event marked the culmination of six years of …

11/23/2025

CODA Research Continues to Advance the Field

We would like to congratulate CODA’s Associate Director of Research and Associate Professor of Psychiatry at OHSU, Dr. Randy Torralva, and Dr. Aaron Janowsky, Professor of Psychiatry and Behavioral Neuroscience at OHSU and of the …

9/16/2019

Research,

Reimagining “access” and heading toward gaps in care:

Recently, I was asked by the Oregon Health Forum to be on a panel of local “experts” to discuss the future of addictions treatment in Oregon. As CODA’s executive director, you can imagine I have …

3/9/2020

Research,

CODA Researcher, Randy Torralva, developing a medication to prevent lethal Fentanyl Overdoses

Since 2017, the anesthetic drug fentanyl has been a key component in increasing deaths from people who use opioids. When fentanyl is mixed into opioids, it creates an often-fatal respiratory failure called “wooden chest syndrome.” …

7/15/2020

Research,